These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11347124)

  • 1. [Significance of education for lifestyle modification in patients with hyperlipidemia].
    Toyohara K; Kurisu A; Fukumoto T; Wada T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():518-23. PubMed ID: 11347124
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperlipidemia complicated with hypertension].
    Takagi S; Shimamoto K
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():738-42. PubMed ID: 11347164
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperlipidemia in patients with ischemic heart disease].
    Murase T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():722-7. PubMed ID: 11347161
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperlipidemia with obesity].
    Ueno M
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():728-32. PubMed ID: 11347162
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of setting standards and guidelines for management of patients with hyperlipidemia].
    Kotake H; Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():492-9. PubMed ID: 11347119
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of coronary heart disease: a nonhormonal approach.
    Lewis V; Hoeger K
    Semin Reprod Med; 2005 May; 23(2):157-66. PubMed ID: 15852201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of primary and secondary prevention trials with lipid-lowering therapy against coronary heart disease].
    Sakai N; Yamashita S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():365-73. PubMed ID: 11347096
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis and prophylaxis of arteriosclerosis].
    Müller F; Wenzel G
    Z Gesamte Inn Med; 1969 Jan; 24(1):25-8. PubMed ID: 5784085
    [No Abstract]   [Full Text] [Related]  

  • 10. [Management of patients with essential hypertension. Clinical recommendations and economic data. Guidelines April 2000. Recommendations of the ANAES].
    Agence Nationale d'Accréditation et d'Evaluation en Santé
    J Mal Vasc; 2000 Dec; 25(5):366-376. PubMed ID: 11148400
    [No Abstract]   [Full Text] [Related]  

  • 11. [Visceral fat syndrome].
    Tokunaga K; Nakamura T; Kubo M; Matsuzawa Y
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1831-5. PubMed ID: 1479226
    [No Abstract]   [Full Text] [Related]  

  • 12. [NCEP Guideline: diet therapy].
    Nakaya N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():538-42. PubMed ID: 11347127
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lifestyle-related diseases: Dyslipidemia].
    Moriyama T
    Nihon Jinzo Gakkai Shi; 2005; 47(1):8-16. PubMed ID: 15754758
    [No Abstract]   [Full Text] [Related]  

  • 14. Short-term effects of an intensive lifestyle modification program on lipid peroxidation and antioxidant systems in patients with coronary artery disease.
    Jatuporn S; Sangwatanaroj S; Saengsiri AO; Rattanapruks S; Srimahachota S; Uthayachalerm W; Kuanoon W; Panpakdee O; Tangkijvanich P; Tosukhowong P
    Clin Hemorheol Microcirc; 2003; 29(3-4):429-36. PubMed ID: 14724371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [44. Normalizing blood lipids--with diet, sports and antilipemic agents].
    Faust M; Krone W
    MMW Fortschr Med; 2003 May; 145(19):I-X; quiz XI-XII. PubMed ID: 12813992
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin resistance and hyperinsulinemia--clinical aspects].
    Kozek E
    Przegl Lek; 1996; 53(9):647-52. PubMed ID: 8992530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cutoff point of visceral fat area as a goal for improving risk factors of arteriosclerosis in patients with glucose intolerance].
    Nagano M; Sasaki H; Kumagai S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():417-20. PubMed ID: 15779415
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adaptive strategies and adaptation after participation in a education program after a first coronary event].
    Henrichon C; Robichaud-Ekstrand S
    Rech Soins Infirm; 2002 Sep; (70):39-65. PubMed ID: 12385191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary risk reduction in office practice.
    Luikart WM
    J La State Med Soc; 1974 Feb; 126(2):51-7. PubMed ID: 4815661
    [No Abstract]   [Full Text] [Related]  

  • 20. [Artherosclerotic ischemic coronary disease. Etiopathogenic considerations].
    Kamel D; Vaissman I; Veloso E; Rotman F; Manhães H
    Arq Bras Endocrinol Metabol; 1969 Dec; 18(3):163-84. PubMed ID: 4935190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.